On February 28, 2014, the FDA issued its most recent unofficial guidance on distribution by manufacturers of research concerning off-label uses. With minor textual revisions,...
The U.S. Supreme Court is currently deciding whether to review the Fourth Circuit’s decision in United States ex rel. Carter v. Halliburton Co., 710...